Surgery in the Patient with Liver Disease

Anesthesiology Clinics

Volumn 27, Issue 4, 2009, Pages 721-737

  Muilenburg, Diego J ^a   Singh, Amrik ^b   Torzilli, Guido ^c   Khatri, Vijay P ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ascites; Cirrhosis; Hepatopulmonary syndrome; Hepatorenal syndrome; Jaundice; Liver dysfunction; Portal hypertension

Indexed keywords

ALBUMIN; ALCOHOL; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANESTHETIC AGENT; ARGIPRESSIN[1 DEAMINO]; ATRACURIUM; BILIRUBIN; CISATRACURIUM; DESFLURANE; DIAZEPAM; FENTANYL; FRESH FROZEN PLASMA; HALOTHANE; ISOFLURANE; MIDAZOLAM; MIVACURIUM; MORPHINE; OXYCODONE; PETHIDINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; THIOPENTAL; TRIACYLGLYCEROL; UNINDEXED DRUG; VASOPRESSIN V2 RECEPTOR; VECURONIUM; VITAMIN K GROUP; VON WILLEBRAND FACTOR;

ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; ALCOHOL INTOXICATION; ALCOHOL LIVER DISEASE; ANEMIA; ANESTHESIA; ASCITES; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BRAIN DISEASE; CACHEXIA; CARDIOMYOPATHY; CHRONIC HEPATITIS; DISEASE COURSE; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; ELECTIVE SURGERY; EMERGENCY SURGERY; ESOPHAGUS VARICES; HEART FAILURE; HEART OUTPUT; HEMODYNAMIC MONITORING; HEPATITIS; HUMAN; HYPONATREMIA; HYPOXEMIA; ISCHEMIA; KIDNEY DYSPLASIA; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FAILURE; LIVER FUNCTION; MALNUTRITION; NONALCOHOLIC FATTY LIVER; NUTRITIONAL STATUS; OBESITY; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION; PEROPERATIVE CARE; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROTHROMBIN TIME; REVIEW; SINGLE DRUG DOSE; STOMACH VARICES; SURGICAL PATIENT; VIRUS HEPATITIS; VITAMIN K DEFICIENCY; WASTING SYNDROME;

EID: 70449711374     PISSN: 19322275     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anclin.2009.09.007     Document Type: Review

References (57)

1. Abdelmalek M.F., and Diehl A.M. Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 91 6 (2007) 1125-1149 ix
2. Adams L.A., Angulo P., and Lindor K.D. Nonalcoholic fatty liver disease. CMAJ 172 7 (2005) 899-905
3. Schuppan D., and Afdhal N.H. Liver cirrhosis. Lancet 371 9615 (2008) 838-851
4. Child C.G., and Turcotte J.G. Surgery and portal hypertension. Major Probl Clin Surg 1 (1964) 1-85
5. Durand F., and Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 42 Suppl 1 (2005) S100-S107
6. Bingener J., Cox D., Michalek J., et al. Can the MELD score predict perioperative morbidity for patients with liver cirrhosis undergoing laparoscopic cholecystectomy?. Am Surg 74 2 (2008) 156-159
7. Farnsworth N., Fagan S.P., Berger D.H., et al. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 188 5 (2004) 580-583
8. Befeler A.S., Palmer D.E., Hoffman M., et al. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 140 7 (2005) 650-654 [discussion: 655]
9. Schneider P.D. Preoperative assessment of liver function. Surg Clin North Am 84 2 (2004) 355-373
10. Lau H., Man K., Fan S.T., et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84 9 (1997) 1255-1259
11. Hemming A.W., Scudamore C.H., Shackleton C.R., et al. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 163 5 (1992) 515-518
12. Hsia C.Y., Lui W.Y., Chau G.Y., et al. Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function. J Am Coll Surg 190 5 (2000) 574-579
13. Poon R.T., and Fan S.T. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 12 1 (2005) 31-37
14. Lee S.G., and Hwang S. How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg 12 1 (2005) 38-43
15. Imamura H., Sano K., Sugawara Y., et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12 1 (2005) 16-22
16. Cabre E., and Gassull M.A. Nutritional aspects of liver disease and transplantation. Curr Opin Clin Nutr Metab Care 4 6 (2001) 581-589
17. Plauth M., Roske A.E., Romaniuk P., et al. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration. Gut 46 6 (2000) 849-855
18. Blei A.T., and Cordoba J. Hepatic encephalopathy. Am J Gastroenterol 96 7 (2001) 1968-1976
19. Bell C.L., and Jeyarajah D.R. Management of the cirrhotic patient that needs surgery. Curr Treat Options Gastroenterol 8 6 (2005) 473-480
20. Shami V.M., Caldwell S.H., Hespenheide E.E., et al. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 9 2 (2003) 138-143
21. Gines P., Cardenas A., Arroyo V., et al. Management of cirrhosis and ascites. N Engl J Med 350 16 (2004) 1646-1654
22. Moller S., and Henriksen J.H. Cardiovascular complications of cirrhosis. Gut 57 2 (2008) 268-278
23. Kuiper J.J., van Buuren H.R., and de Man R.A. Ascites in cirrhosis: a review of management and complications. Neth J Med 65 8 (2007) 283-288
24. Saab S., Nieto J.M., Lewis S.K., et al. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev 4 (2006) CD004889
25. Russo M.W., Sood A., Jacobson I.M., et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol 98 11 (2003) 2521-2527
26. Azoulay D., Buabse F., Damiano I., et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 193 1 (2001) 46-51
27. Gil A., Martinez-Regueira F., Hernandez-Lizoain J.L., et al. The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension. Eur J Surg Oncol 30 1 (2004) 46-52
28. Dong M.H., and Saab S. Complications of cirrhosis. Dis Mon 54 7 (2008) 445-456
29. Blei A.T., Mazhar S., Davidson C.J., et al. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome. J Clin Gastroenterol 41 Suppl 3 (2007) S323-S329
30. Zambruni A., Trevisani F., Caraceni P., et al. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol 44 5 (2006) 994-1002
31. Wong F., Girgrah N., Graba J., et al. The cardiac response to exercise in cirrhosis. Gut 49 2 (2001) 268-275
32. Rodriguez-Roisin R., Krowka M.J., Herve P., et al. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 24 5 (2004) 861-880
33. Hanje A.J., and Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol 4 5 (2007) 266-276
34. Schenk P., Schoniger-Hekele M., Fuhrmann V., et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125 4 (2003) 1042-1052
35. Ziser A., Plevak D.J., Wiesner R.H., et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90 1 (1999) 42-53
36. Teh S.H., Nagorney D.M., Stevens S.R., et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132 4 (2007) 1261-1269
37. Wahlstrom K., Ney A.L., Jacobson S., et al. Trauma in cirrhotics: survival and hospital sequelae in patients requiring abdominal exploration. Am Surg 66 11 (2000) 1071-1076
38. Franzetta M., Raimondo D., Giammanco M., et al. Prognostic factors of cirrhotic patients in extra-hepatic surgery. Minerva Chir 58 4 (2003) 541-544
39. Friedman L.S. The risk of surgery in patients with liver disease. Hepatology 29 6 (1999) 1617-1623
40. Sahin H., Pirat A., and Arslan G. Anaesthesia and surgery in patients with abnormal preoperative liver enzymes. Eur J Anaesthesiol 24 5 (2007) 465-467
41. Gelman S., Fowler K.C., and Smith L.R. Liver circulation and function during isoflurane and halothane anesthesia. Anesthesiology 61 6 (1984) 726-730
42. Moller S., and Henriksen J.H. Cardiopulmonary complications in chronic liver disease. World J Gastroenterol 12 4 (2006) 526-538
43. Baden J.M., Serra M., Fujinaga M., et al. Halothane metabolism in cirrhotic rats. Anesthesiology 67 5 (1987) 660-664
44. Gut J., Christen U., and Huwyler J. Mechanisms of halothane toxicity: novel insights. Pharmacol Ther 58 2 (1993) 133-155
45. Servin F., Cockshott I.D., Farinotti R., et al. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth 65 2 (1990) 177-183
46. Tegeder I., Lotsch J., and Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 37 1 (1999) 17-40
47. Lebrault C., Berger J.L., D'Hollander A.A., et al. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis. Anesthesiology 62 5 (1985) 601-605
48. Cook D.R., Freeman J.A., Lai A.A., et al. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 69 6 (1992) 580-585
49. Torzilli G., Makuuchi M., Inoue K., et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134 9 (1999) 984-992
50. Tonnesen H., and Kehlet H. Preoperative alcoholism and postoperative morbidity. Br J Surg 86 7 (1999) 869-874
51. Mansour A., Watson W., Shayani V., et al. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122 4 (1997) 730-735 [discussion: 735-6]
52. Redai I., Emond J., and Brentjens T. Anesthetic considerations during liver surgery. Surg Clin North Am 84 2 (2004) 401-411
53. Stawicki S.P., Schwarz N.S., Schrag S.P., et al. Application of vacuum-assisted therapy in postoperative ascitic fluid leaks: an integral part of multimodality wound management in cirrhotic patients. J Burns Wounds 6 (2007) e7
54. Mihas A.A., Toussaint J., Hsu H.S., et al. Spontaneous bacterial peritonitis in cirrhosis: clinical and laboratory features, survival and prognostic indicators. Hepatogastroenterology 39 6 (1992) 520-522
55. Fernandez J., Navasa M., Planas R., et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133 3 (2007) 818-824
56. Faust T.W., and Reddy K.R. Postoperative jaundice. Clin Liver Dis 8 1 (2004) 151-166
57. Rizvon M.K., and Chou C.L. Surgery in the patient with liver disease. Med Clin North Am 87 1 (2003) 211-227